Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Chen

Showing results (471-480 of 491) with videos related to

Pageof 50
Sort By:
Blood Advances|October 12, 2021
Anti-CD25 radioimmunotherapy with BEAM autologous hematopoietic cell transplantation conditioning in Hodgkin lymphomaAlex F Herrera, Joycelynne Palmer, Vikram Adhikarla, et al.
Blood|February 23, 2023
Dual targeting of CD19 and CD22 with bicistronic CAR-T cells in patients with relapsed/refractory large B-cell lymphomaClaire Roddie, Lazaros J Lekakis, Maria A V Marzolini, et al.
Global Spine Journal|June 30, 2022
We Choose to Call it 'Degenerative Cervical Myelopathy': Findings of AO Spine RECODE-DCM, an International and Multi-Stakeholder Partnership to Agree a Standard Unifying Term and Definition for a DiseaseBenjamin M Davies, Danyal Z Khan, Kara Barzangi, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 10, 2012
Hodgkin lymphoma, version 2.2012 featured updates to the NCCN guidelinesRichard T Hoppe, Ranjana H Advani, Weiyun Z Ai, et al.
BMJ Open|June 9, 2022
Development of a core measurement set for research in degenerative cervical myelopathy: a study protocol (AO Spine RECODE-DCM CMS)Benjamin M Davies, Alvaro Yanez Touzet, Oliver D Mowforth, et al.
The New England Journal of Medicine|December 12, 2017
Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's LymphomaJoseph M Connors, Wojciech Jurczak, David J Straus, et al.
Global Spine Journal|November 23, 2017
A Clinical Practice Guideline for the Management of Patients With Degenerative Cervical Myelopathy: Recommendations for Patients With Mild, Moderate, and Severe Disease and Nonmyelopathic Patients With Evidence of Cord CompressionMichael G Fehlings, Lindsay A Tetreault, K Daniel Riew, et al.
The Oncologist|July 29, 2020
Checkpoint Blockade Treatment May Sensitize Hodgkin Lymphoma to Subsequent TherapyNicole A Carreau, Orrin Pail, Philippe Armand, et al.
The Oncologist|April 11, 2020
Impact of Treatment Beyond Progression with Immune Checkpoint Blockade in Hodgkin LymphomaReid W Merryman, Nicole A Carreau, Ranjana H Advani, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 1, 2010
Definition and classification of hyperkinetic movements in childhoodTerence D Sanger, Daofen Chen, Darcy L Fehlings, et al.
Pageof 50

Showing results (471-480 of 491) with videos related to

Sort By:
Pageof 50
Blood Advances|October 12, 2021
Anti-CD25 radioimmunotherapy with BEAM autologous hematopoietic cell transplantation conditioning in Hodgkin lymphomaAlex F Herrera, Joycelynne Palmer, Vikram Adhikarla, et al.
Blood|February 23, 2023
Dual targeting of CD19 and CD22 with bicistronic CAR-T cells in patients with relapsed/refractory large B-cell lymphomaClaire Roddie, Lazaros J Lekakis, Maria A V Marzolini, et al.
Global Spine Journal|June 30, 2022
We Choose to Call it 'Degenerative Cervical Myelopathy': Findings of AO Spine RECODE-DCM, an International and Multi-Stakeholder Partnership to Agree a Standard Unifying Term and Definition for a DiseaseBenjamin M Davies, Danyal Z Khan, Kara Barzangi, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 10, 2012
Hodgkin lymphoma, version 2.2012 featured updates to the NCCN guidelinesRichard T Hoppe, Ranjana H Advani, Weiyun Z Ai, et al.
BMJ Open|June 9, 2022
Development of a core measurement set for research in degenerative cervical myelopathy: a study protocol (AO Spine RECODE-DCM CMS)Benjamin M Davies, Alvaro Yanez Touzet, Oliver D Mowforth, et al.
The New England Journal of Medicine|December 12, 2017
Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's LymphomaJoseph M Connors, Wojciech Jurczak, David J Straus, et al.
Global Spine Journal|November 23, 2017
A Clinical Practice Guideline for the Management of Patients With Degenerative Cervical Myelopathy: Recommendations for Patients With Mild, Moderate, and Severe Disease and Nonmyelopathic Patients With Evidence of Cord CompressionMichael G Fehlings, Lindsay A Tetreault, K Daniel Riew, et al.
The Oncologist|July 29, 2020
Checkpoint Blockade Treatment May Sensitize Hodgkin Lymphoma to Subsequent TherapyNicole A Carreau, Orrin Pail, Philippe Armand, et al.
The Oncologist|April 11, 2020
Impact of Treatment Beyond Progression with Immune Checkpoint Blockade in Hodgkin LymphomaReid W Merryman, Nicole A Carreau, Ranjana H Advani, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 1, 2010
Definition and classification of hyperkinetic movements in childhoodTerence D Sanger, Daofen Chen, Darcy L Fehlings, et al.
Pageof 50